Search results
New XSeed Labs Research Team Starts Activity in the U.S. in Collaboration With Boehringer Ingelheim
Morningstar· 4 days agoA new research team at XSeed Labs - a collaboration between BioMed X and Boehringer Ingelheim, will develop disease models to understand wound healing and ...
In trial over cancer claims, pharma executive questioned about proper storage, handling of Zantac
Chicago Sun-Times· 5 days agoAngela Valadez, an 89-year-old woman from Brookfield, alleges that Zantac caused her colon cancer....
CDSCO approves antibody for rare skin disorder in Indian adults
Investing.com· 5 days agoCDSCO approves antibody for rare skin disorder in Indian adults
FTC targets 300 Big Pharma 'junk patents,' sends warning letters to top drugmakers
BenefitsPRO· 5 days agoThe Federal Trade Commission is stepping up its crackdown on so-called "junk patents," which it...
Zantac pharma exec calls heartburn drug safe and effective during testimony against cancer claims
Chicago Sun-Times· 6 days agoThe suit is the first of thousands throughout the country to make it to a jury trial. Angela Valadez...
Eastowne Business Park to receive infrastructure upgrades
St. Joseph News-Press, Mo. via Yahoo Finance· 7 hours agoMay 19—Efforts are ramping up to attract additional business near the outskirts of town. The city of St. Joseph is using $3 million from its 2024 Capital Improvements Program tax to install ...
Zealand Pharma Announces Financial Results for the First Quarter of 2024
Benzinga· 4 days agoStrong performance in the first quarter of 2024 paving the way for important data read-outs across differentiated obesity assets in the second quarter. Copenhagen, Denmark, May 16, 2024 – Zealand ...
Reasons to Add Veeva Systems (VEEV) Stock to Your Portfolio
Zacks via Yahoo Finance· 5 days agoStrategic Deals: We are upbeat about Veeva Systems’ inking of a slew of notable deals. In February,...
Investors put $400M into biotech licensing obesity drugs from China
BioPharma Dive via Yahoo Finance· 4 days agoThe biotech, tentatively named Hercules CM Newco, has rights to three incretin drugs discovered by...
Anticipation mounts as Insmed's bronchiectasis therapy nears phase 3 completion
BioPharma-Reporter· 7 days agoThe therapy has sparked significant anticipation within the medical community ahead of its phase 3...
